MTOR and hepatocellular carcinoma: It is identified by Song et.al that lncRNA CASC11drives HCC progression by recruiting EIF4A3 to enhance E2F1 stability, which activates NF-κB signaling and PI3K/AKT/mTOR pathway and further upregulates glycolysis and the expression of PD-L1 [168].